Characteristics of Patients with Hospital-acquired Influenza A (H1N1)pdm09 Virus Admitted to the Intensive Care Unit
Overview
Infectious Diseases
Authors
Affiliations
Background: Influenza A (H1N1)pdm09 virus infection acquired in the hospital and in critically ill patients admitted to the intensive care unit (ICU) has been poorly characterized.
Aim: To assess the clinical impact of hospital-acquired infection with influenza A (H1N1)pdm09 virus in critically ill patients.
Methods: Analysis of a prospective database of the Spanish registry (2009-2015) of patients with severe influenza A admitted to the ICU. Infection was defined as hospital-acquired when diagnosis and starting of treatment occurred from the seventh day of hospital stay with no suspicion on hospital admission, and community-acquired when diagnosis was established within the first 48 h of admission.
Findings: Of 2421 patients with influenza A (H1N1)pdm09 infection, 224 (9.3%) were classified as hospital-acquired and 1103 (45.6%) as community-acquired (remaining cases unclassified). Intra-ICU mortality was higher in the hospital-acquired group (32.9% vs 18.8%, P < 0.001). Independent factors associated with mortality were hospital-acquired influenza A (H1N1)pdm09 infection (odds ratio: 1.63; 95% confidence interval: 1.37-1.99), APACHE II score on ICU admission (1.09; 1.06-1.11), underlying haematological disease (3.19; 1.78-5.73), and need of extrarenal depuration techniques (4.20; 2.61-6.77) and mechanical ventilation (4.34; 2.62-7.21).
Conclusion: Influenza A (H1N1)pdm09 infection acquired in the hospital is an independent factor for death in critically ill patients admitted to the ICU.
Prediction of hospital-acquired influenza using machine learning algorithms: a comparative study.
Cho Y, Lee H, Kim J, Yoo K, Choi J, Lee Y BMC Infect Dis. 2024; 24(1):466.
PMID: 38698304 PMC: 11067145. DOI: 10.1186/s12879-024-09358-1.
Comparison of 28-Day Mortality Between Hospital- and Community-Acquired Influenza Patients.
Bilgin H, Basari T, Pazar N, Kucuker I, Can-Sarinoglu R Infect Dis Clin Microbiol. 2024; 5(3):231-238.
PMID: 38633557 PMC: 10985807. DOI: 10.36519/idcm.2023.243.
Hanna F, Alameddine I, Zaraket H, Alkalamouni H, El-Fadel M PLoS One. 2023; 18(10):e0290124.
PMID: 37878553 PMC: 10599543. DOI: 10.1371/journal.pone.0290124.
Linares M, Santos Larregola L, de Yebenes P, Galilea J BMC Prim Care. 2023; 24(1):202.
PMID: 37789255 PMC: 10546758. DOI: 10.1186/s12875-023-02160-z.
Low Z, Wong K, Yip A, Choo W Curr Res Microb Sci. 2023; 5:100202.
PMID: 37700857 PMC: 10493511. DOI: 10.1016/j.crmicr.2023.100202.